DrugDashboards

Diluent

Sodium Chloride · SODIUM CHLORIDE 4.5 mg/.5mL · Injection · Subcutaneous · Sanofi Vaccines US Inc.

NDC 49281-0912-05 · 5 VIAL, SINGLE-DOSE in 1 PACKAGE / .6 mL in 1 VIAL, SINGLE-DOSE · BLA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 1.5% of the time — roughly 10× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

1.5%chance of a new FDA shortage posting for sodium chloride (injectable) in the next 90 days

sterile injectable · 13 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 10× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $77.88 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
BLA103915
TE code
—
Approval date
—
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sodium Chloride (Injection)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationSODIUM CHLORIDE 450 mg/100mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 450 mg/50mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 3, 2026
B. Braun Medical Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Medical Care de Mexico, S.A. de C.V.SODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 2, 2026
Fresenius Medical Care Renal Therapies Group, LLCSODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Liebel-Flarsheim Company LLCSODIUM CHLORIDE .9 mg/mLJul 15, 2026Sep 2, 2026
Nephron Pharmaceuticals CorporationSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Sanofi Vaccines US Inc.SODIUM CHLORIDE 4.5 mg/.5mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Aug 31, 2026
Hikma Pharmaceuticals USA Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Diluent — NDC 49281-0912-05," retrieved September 3, 2026, https://drugdashboards.com/drug/49281091205.

Free to cite with attribution — see how the data is put together.